期刊文献+

Prognostic and clinicopathological features of E-cadherin,α-catenin,β-catenin,γ-catenin and cyclin D_1 expression in human esophageal squamous cell carcinoma 被引量:30

Prognostic and clinicopathological features of E-cadherin,α-catenin,β-catenin,γ-catenin and cyclin D_1 expression in human esophageal squamous cell carcinoma
下载PDF
导出
摘要 AIM: To investigate the expression of E-cadherin, α-catenin,β-catenin, γ-catenin and cyclin D1 in patients with esophageal squamous cell carcinoma (ESCC), and analyze their interrelationship with clinicopathological variables and their effects on prognosis. METHODS: Expression of E-cadherin, α-catenin, β-catenin, γ-catenin and cyclin D1 was determined by EnVision or SABC immunohistochemical technique in patients with ESCC consecutively, their correlation with clinical characteristics was evaluated and analyzed by univariate analysis. RESULTS:The reduced expression rate of E-cadherin, α-catenin, β-catenin and γ-catenin was 88.7%, 69.4%, 35.5% and 53.2%, respectively. Cyclin D1 positive expression ratewas 56.5%. Expression of γ-catenin was inversely correlated with the degree of tumor differentiation and lymph node metastasis (x^2=4.183 and x^2=5.035, respectively, P<0.05), whereas the expression of E-cadherin was correlated only with the degree of differentiation (x^2=5.769, P<0.05). Reduced expression of E-cadherin and γ-catenin was associated with poor differentiation of tumor, reduced expression of γ-catenin was also associated with lymph node metastasis. There obviously existed an inverse correlation between level of E-cadherin and γ-catenin protein and survival. The 3-year survival rates were 100% and 56% in E-cadherin preserved expression group and inreduced expression one and were 78% and 48% in γ-catenin preserved expression group and in reduced expression one, respectively. The differences were both statistically significant. Correlation analysis showed the expression level of α-catenin correlated with that of E-cadherin and β-catenin (P<0.05). CONCLUSION: The reduced expression of E-cadherin and γ-catenin, but not α-catenin, β-catenin and cyclin D1, implies more aggressive malignant behaviors of esophageal carcinoma cells and predicts the poor prognosis of patients. AIM:To investigate the expression of E-cadherin,α-catenin, β-catenin,γ-catenin and cyclin D_1 in patients with esophageal squamous cell carcinoma(ESCC),and analyze their interrelationship with clinicopathological variables and their effects on prognosis. METHODS:Expression of E-cadherin,α-catenin,β-catenin, γ-catenin and cyclin D_1 was determined by EnVision or SABC immunohistochemical technique in patients with ESCC consecutively,their correlation with clinical characteristics was evaluated and analyzed by univariate analysis. RESULTS:The reduced expression rate of E-cadherin,α- catenin,β-catenin and γ-catenin was 88.7%,69.4%,35.5% and 53.2%,respectively.Cyclin D1 positive expression rate was 56.5%.Expression of γ-catenin was inversely correlated with the degree of tumor differentiation and lymph node metastasis(X^2=4.183 and X^2=5.035,respectively,P<0.05), whereas the expression of E-cadherin was correlated only with the degree of differentiation(X^2=5.769,P<0.05). Reduced expression of E-cadherin and γ-catenin was associated with poor differentiation of tumor,reduced expression of γ-catenin was also associated with lymph node metastasis.There obviously existed an inverse correlation between level of E-cadherin and γ-catenin protein and survival.The 3-year survival rates were 100% and 56% in E-cadherin preserved expression group and in reduced expression one and were 78% and 48% in γ-catenin preserved expression group and in reduced expression one, respectively.The differences were both statistically significant.Correlation analysis showed the expression level of α-catenin correlated with that of E-cadherin and β-catenin (P<0.05). CONCLUSION:The reduced expression of E-cadherin and γ-catenin,but not α-catenin,β-catenin and cyclin D1,implies more aggressive malignant behaviors of esophageal carcinoma cells and predicts the poor prognosis of patients.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第22期3235-3239,共5页 世界胃肠病学杂志(英文版)
基金 Supported by a grant of Shantou University Research & Development Fund,No.L03002
  • 相关文献

参考文献2

二级参考文献35

  • 1Zheng Q;Tang ZY;Xue Q;Shi DR,Song HY,Tang HB.Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor[J],2000(11).
  • 2Ono T;Yamanoi A;Nazmy El Assal O;Kohno H,Nagasue N.Adjuvantchemotherapy after resection of hepatocellular carcinoma causes deteriorationof long-term prognosis in cirrhotic patients: metaanalysis of threerandomized controlled trials,2001.
  • 3Yao FY;Ferrell L;Bass NM;Watson JJ,Bacchetti P,Venook A,AscherNL,Roberts JP.Liver transplantation for hepatocellular carcinoma:expansion of the tumor size limits does not adversely impact survival[J],2001.
  • 4Ouchi K;Sugawara T;Fujiya T;Kamiyama Y,Kakugawa Y,Mikuni J,Yamanami H,Nakagawa K.Prediction of recurrence and extratumor spreadof hepatocellular carcinoma following resection[J],2000.
  • 5Poon RT;Fan ST;Ng IO;Lo CM,Liu CL,Wong J.Different riskfactors and prognosis for early and late intrahepatic recurrence after resectionof hepatocellular carcinoma,2000.
  • 6Marsh JW;Dvorchik I;Bonham CA;Iwatsuki S.Is the pathologic TNMstaging system for patients with hepatoma predictive of outcome?[J],2000.
  • 7Yamanaka J;Ya naka N;Nakasho K;Tanaka T,Ando T,Yasui C,Kuroda N,Takata M,Maeda S,Matsushita K,Uematsu K,Ok amoto E.Clinicopathologic analysis of stage Ⅱ-m hepatocellular carcinoma showingearly massive recurrence after liver resection[J],2000(10).
  • 8Hino N;Higashi T;Nouso K;Nakatsukasa H,Urabe Y,Kinugasa N,Yoshida K,Ashida K,Ohguchi S,Tsuji T.Proliferating cell nuclearantigen and grade of malignancy in small hepatocellular carcinoma-evaluation in US-guided specimens,1997.
  • 9Wu PC;Fang JW;Lau VK.Classification ofhepatocellular carcinoma according to hepatocellular and biliarydifferentiation markers,1996.
  • 10Suehiro T;Matsumata T;Itasaka H;Yamamoto K,Kawahara N,Sugimachi K.Clinicopathologic features and prognosis of resectedhepatocellular carcinomas of varied sizes with special reference toproliferating cell nuclear antigen[J],1995.

共引文献31

同被引文献122

引证文献30

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部